In this study, researchers investigated long-term outcomes from a real-world cohort of patients with stage IV melanoma treated with pembrolizumab following progression on prior therapies.

Investigators analyzed IBD subtypes and their associated risks of radical prostatectomy complications among a cohort of patients with prostate cancer to fill a knowledge gap.

In this study, researchers sought to determine whether Medicaid expansion led to improvements in survival for patients with resectable NSCLC.

Lymphir is supplied as a 300mcg lyophilized cake in a single-dose vial for reconstitution and further dilution.

Investigators sought to examine the connection between a diagnosis of cancer within 12 months following a diagnosis of hiccups ...

Five-year survival for all pediatric cancers increased from 63 percent in mid-1970s to 87 percent in 2015 to 2021.

FZOCUS-1 assessed the safety and efficacy of fuzuloparib alone and in combination with apatinib for patients with newly diagnosed or advanced ovarian cancer.

When cancer subtypes were examined, the analysis revealed that phototherapy was linked to a 40% increased odds of blood cancers. More modest associations were observed for solid organ cancers and ...

In order to understand how patients are affected by receiving notification of their breast density, Australian researchers conducted a randomized, multi-arm trial of 2401 women with dense breasts.

Median progression-free survival was 22 months, overall survival was 152 months among patients with newly diagnosed MM.

PRRT retreatment may be well tolerated and confer a survival benefit in patients with well-differentiated, metastatic neuroendocrine tumors, a study suggests.

Researchers reported on patient acceptance of an e-consent tool for asynchronous delivery of study information and for receiving consent from patients.